Adjuvant chemotherapy in endometrial cancer

Int J Gynecol Cancer. 2010 Oct;20(11 Suppl 2):S57-9. doi: 10.1111/IGC.0b013e3181f749fd.

Abstract

The indications for adjuvant therapy in endometrial cancer are briefly reviewed. The importance of systemic adjuvant therapy is emphasized. A short summary of randomized studies on adjuvant chemotherapy versus radiotherapy and on adjuvant sequential chemotherapy plus radiotherapy versus radiotherapy alone is given. On the basis of the present results from randomized trials, a combination of adjuvant radiotherapy and platinum-based chemotherapy seems to be most effective.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Chemotherapy, Adjuvant
  • Endometrial Neoplasms / drug therapy*
  • Endometrial Neoplasms / radiotherapy
  • Female
  • Humans
  • Platinum Compounds / therapeutic use
  • Radiotherapy, Adjuvant
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Platinum Compounds